DOPAMINE, SEROTONIN AND SYMPTOMS OF SCHIZOPHRENIA

被引:0
|
作者
VINAROVA, E
VINAR, O
机构
[1] DIST HLTH CTR, DEPT PSYCHIAT, CS-29301 MLADA BOLESLAV, CZECHOSLOVAKIA
[2] STATE DRUG CONTROL INST, CS-10041 PRAGUE 10, CZECHOSLOVAKIA
[3] INST ORGAN CHEM BIOCHEM, JOINT LAB, CS-10041 PRAGUE 10, CZECHOSLOVAKIA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S60 / S60
页数:1
相关论文
共 50 条
  • [31] Dopamine- and serotonin-receptors in schizophrenia:: results of imaging-studies and implications for pharmacotherapy in schizophrenia
    Kasper, S
    Tauscher, J
    Küfferle, B
    Barnas, C
    Pezawas, L
    Quiner, S
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 : 83 - 89
  • [32] Network Driven Discovery of Dopamine, Serotonin and Glutamate Receptors as Key Players in Schizophrenia
    Martha, Sushma Rani
    Patri, Manorama
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2020, 79 (05): : 406 - 412
  • [33] Functional associations of the gut microbiome with dopamine, serotonin, and BDNF in schizophrenia: a pilot study
    Ghorbani, Mahin
    Stephen Joseph, Gerard Benedict
    Mei Mei, Tew
    Ramly, Siti Salwa
    Muhamad Rasat, Muhammad Arif
    Croft, Lawrence
    Parimannan, Sivachandran
    Rajandas, Heera
    Lee, Su Yin
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [34] Dopamine and serotonin receptor occupancy of long acting injectable risperidone in patients with schizophrenia
    Potkin, SG
    Mukherjee, J
    Gharabawi, G
    Collins, D
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S269 - S270
  • [35] Dopamine and serotonin system gene polymorphisms in early age of onset schizophrenia.
    Golimbet, VE
    Manandyan, KK
    Aksenova, MG
    Kozlova, IA
    Abramova, LI
    Kaleda, VG
    Oleichik, IV
    Yurov, YB
    Nosikov, VV
    Trubnikov, VI
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 526 - 527
  • [36] Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia
    Silver, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (06) : 305 - 313
  • [37] Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia
    Singh, AN
    Barlas, C
    Saeedi, H
    Mishra, RK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2003, 28 (01): : 39 - 47
  • [38] Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
    Maini, Kunal
    Hollier, Janice W.
    Gould, Haley
    Bollich, Victoria
    LaForge, John John
    Cornett, Elyse M.
    Edinoff, Amber N.
    Kaye, Adam M.
    Kaye, Alan D.
    HEALTH PSYCHOLOGY RESEARCH, 2021, 9 (01):
  • [39] Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
    Hietala, J
    Syvälahti, E
    Vilkman, H
    Vuorio, K
    Räkköläinen, V
    Bergman, J
    Haaparanta, M
    Solin, O
    Kuoppamäki, M
    Eronen, E
    Ruotsalainen, U
    Salokangas, RKR
    SCHIZOPHRENIA RESEARCH, 1999, 35 (01) : 41 - 50
  • [40] Developmental pathology, dopamine, and stress: A model for the age of onset of schizophrenia symptoms
    Thompson, JL
    Pogue-Geile, MF
    Grace, AA
    SCHIZOPHRENIA BULLETIN, 2004, 30 (04) : 875 - 900